Fundraising FoxRadImmune Therapeutics
Tarrytown, US · Founded 2016 · Delaware corporation
Find your way into RadImmune Therapeutics
Sign up to see every warm intro you have to RadImmune Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RadImmune Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JH
Jack HidaryNamed on SEC filing
JB
Josh BeckerNamed on SEC filing
RL
Ron LennoxNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$13.6M disclosed across 1 round · 2019
▶$13.6MraisedAug 2019 · 14 investors · Other Health CareRule 506(b)
▶$13.6MraisedAug 2019 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jack HidaryExecutive Officer, Director
- Josh BeckerDirector
- Ron LennoxDirector
- Offering amount
- $21.8M
- Amount sold
- $13.6M
- Minimum investment
- $1
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has RadImmune Therapeutics raised?
- RadImmune Therapeutics has disclosed $13.6M raised across 1 round.
- Where is RadImmune Therapeutics headquartered?
- RadImmune Therapeutics is headquartered in Tarrytown, US.